President Makes NCAB Appointments
WASHINGTON--President Clin-ton has reappointed Barbara K. Rimer, DrPH, to a second 2-year term as chair of the National Cancer Advisory Board (NCAB) and appointed Richard J. Boxer, MD, professor of family and community medicine, Medical College of Wisconsin, Milwaukee, to a full 6-year term. Dr. Boxer had served on the board for a year to complete the term of Paul Calabresi, MD, who resigned to join the President's Cancer Panel.
WASHINGTON--President Clin-ton has reappointed Barbara K. Rimer,DrPH, to a second 2-year term as chair of the National CancerAdvisory Board (NCAB) and appointed Richard J. Boxer, MD, professorof family and community medicine, Medical College of Wisconsin,Milwaukee, to a full 6-year term. Dr. Boxer had served on theboard for a year to complete the term of Paul Calabresi, MD, whoresigned to join the President's Cancer Panel.
The President also appointed four new members: Frederick P. Li,MD, head of the Division of Cancer Epidemiology, Dana-Farber CancerInstitute; Ivor Royston, MD, president and CEO of the Sidney KimmelCancer Center, San Diego; Ellen L. Stovall, executive directorof the National Coalition for Cancer Survivorship; and SandraMillon-Underwood, PhD, associate professor, University of Wisconsin,Milwaukee.
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
